Loading organizations...
Key people at Hevolution.
Hevolution Foundation is a non-profit organization dedicated to extending healthy human lifespan by reframing aging as a treatable biological process. It acts as a global catalyst, funding geroscience research and providing strategic investments. The organization accelerates discoveries and their translation into therapies, emphasizing aging's fundamental biology.
Established from the insight that medical advancements inadequately address unhealthy aging, Hevolution is driven by a conviction that everyone deserves to age well. While specific founders are not detailed, the initiative arose from a global imperative to focus scientific and business efforts on prolonging healthspan, spearheading this critical worldwide endeavor.
Hevolution Foundation supports researchers, academic institutions, and biotech innovators through grants and strategic capital. Its mission is to redefine aging, shifting the narrative from decline to sustained opportunity. The organization envisions a future where scientific breakthroughs enable all individuals to experience extended periods of health and vitality.
Key people at Hevolution.
Hevolution has 4 tracked investments across 4 companies. The latest tracked deal is $55.0M Series B in Aeovian Pharmaceuticals in December 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 16, 2025 | Aeovian Pharmaceuticals | $55.0M Series B | Youssef Bennani, Themasap Khan | Kari Luther Rosbeck, Apollo Health Ventures, Foresite Capital, Sofinnova Investments, SymBiosis, Jane Yang, PHD |
| Jan 1, 2025 | Tune Therapeutics | $180.0M Series B | Hevolution, Yosemite | NEW Enterprise Associates, Versant Ventures |
| Aug 21, 2024 | Vandria | $37.9M Grant / Series A | Dolby Family Ventures, Hevolution | — |
| Apr 1, 2024 | Rubedo Life Sciences | $40.0M Series A | Ahren Innovation Capital, Khosla Ventures | 7percent Ventures, Alumni Ventures, Catalio Capital, Gaingels, MarsBio, Moonstone Venture Capital, Presight Capital, Refactor Capital, SOSV, The House Fund, The Longevity Fund, Tiger Global Management, TLV Partners, Tuesday Capital, Amjad Masad, Andy Coravos, Anne Wojcicki, Balaji Srinivasan, DAN Ciporin, Dylan Field, Fidji Simo, Justin Mateen, Rich Miner, Varsha RAO, Cerigo Investments, Italian Angels For Growth, LongeVC, Modi Ventures, R42 Group, Shanda Group |